Glioma cells can recruit numerous kinds of cell including immune cells that move to the niche by secreting cytokines (like TGF-β, GM-CSF) (13, 14) and then revise these cells into ‘tumor-friendly’ phenotypes (15). The gene discussed is TGFB1; the disease is central nervous system cancer.